Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis
出版年份 2010 全文链接
标题
Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 162, Issue 7, Pages 1470-1484
出版商
Wiley
发表日期
2010-12-23
DOI
10.1111/j.1476-5381.2010.01183.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- The role of HMGB1 in the pathogenesis of rheumatic disease
- (2010) Ulf Andersson et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- U.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab
- (2010) S. J. Lemery et al. CLINICAL CANCER RESEARCH
- Toll-like Receptor 2 Signaling in CD4+ T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease
- (2010) Joseph M. Reynolds et al. IMMUNITY
- Economic impact of rheumatoid arthritis (RA) biotherapies in France
- (2010) Milka Maravic JOINT BONE SPINE
- Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: A meta-analysis
- (2010) Ji Ying Tan et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Transcriptional Regulation of the Endogenous Danger Signal Tenascin-C: A Novel Autocrine Loop in Inflammation
- (2010) Fui G. Goh et al. JOURNAL OF IMMUNOLOGY
- Endogenous ligands of TLR2 and TLR4: agonists or assistants?
- (2010) Clett Erridge JOURNAL OF LEUKOCYTE BIOLOGY
- Enhanced antibody half-life improves in vivo activity
- (2010) Jonathan Zalevsky et al. NATURE BIOTECHNOLOGY
- Local Interleukin-1-Driven Joint Pathology Is Dependent on Toll-Like Receptor 4 Activation
- (2009) Shahla Abdollahi-Roodsaz et al. AMERICAN JOURNAL OF PATHOLOGY
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*
- (2009) Mark Tidswell et al. CRITICAL CARE MEDICINE
- The role of Toll-like receptors in chronic inflammation
- (2009) Stefan K. Drexler et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
- (2009) Anja Strangfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates
- (2009) Y. A. Yeung et al. JOURNAL OF IMMUNOLOGY
- Structure of IL-17A in Complex with a Potent, Fully Human Neutralizing Antibody
- (2009) Stefan Gerhardt et al. JOURNAL OF MOLECULAR BIOLOGY
- The Design and Characterization of Oligospecific Antibodies for Simultaneous Targeting of Multiple Disease Mediators
- (2009) Nazzareno Dimasi et al. JOURNAL OF MOLECULAR BIOLOGY
- Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
- (2009) Josef S Smolen et al. LANCET
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease
- (2009) Kim Midwood et al. NATURE MEDICINE
- Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
- (2009) L. A. J. O'Neill et al. PHARMACOLOGICAL REVIEWS
- Toll-like receptors and NOD-like receptors in rheumatic diseases
- (2009) William J McCormack et al. ARTHRITIS RESEARCH & THERAPY
- The role of Toll-like receptors in rheumatoid arthritis
- (2009) Qi-Quan Huang et al. Current Rheumatology Reports
- The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
- (2008) J P Leombruno et al. ANNALS OF THE RHEUMATIC DISEASES
- Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production
- (2008) Shahla Abdollahi-Roodsaz et al. ARTHRITIS AND RHEUMATISM
- Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis
- (2008) Caroline Ospelt et al. ARTHRITIS AND RHEUMATISM
- Use of pharmacokinetic/ pharmacodynamic modelling for starting dose selection in first-in-human trials of high-risk biologics
- (2008) Balaji M. Agoram BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Disease status, costs and quality of life of patients with rheumatoid arthritis in France: The ECO-PR Study
- (2008) Gisela Kobelt et al. JOINT BONE SPINE
- Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis
- (2008) Shahla Abdollahi-Roodsaz et al. JOURNAL OF CLINICAL INVESTIGATION
- In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification
- (2008) Stefan Steidl et al. MOLECULAR IMMUNOLOGY
- The British Society for Rheumatology Biologics Register: 6 years on
- (2008) K. L. Hyrich et al. RHEUMATOLOGY
- Primer: Toll-like receptor signaling pathways—what do rheumatologists need to know?
- (2008) Luke AJ O'Neill Nature clinical practice. Rheumatology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started